Events

Join Knobbe Martens Partners on Tuesday, July 23 (9:00 am PST | 12:00 noon EST) for a live webinar event covering "Preparing for Biosimilars: Key Points for Participating in the U.S. Regulatory Framework."

In view of the U.S. approval process for biosimilars, companies are gearing up to either produce their own biosimilar products, or to defend against their entry onto the market. While the Biologics Price Competition and Innovation Act (BPCIA) spells out many of the requirements, the pathway for approval is complicated. Our panel of attorneys will discuss the features of the BPCIA and how it operates for both approved biologics as well as biosimilar entrants. They will also make some predictions on its impact for life science companies.

The webinar will be 60 minutes, complete with Q&A.

One hour of California CLE credit available for attorneys. Washington CLE credit pending.